Flowers on a vine Flowers on a vine Flowers on a vine

Treatment With REBYOTA

Access information about REBYOTA administration, patient experiences, and more.

One dose one visit

  • REBYOTA is a single-dose treatment—delivered at your doctor’s office, and is administered within minutes1
  • REBYOTA is delivered rectally to your gut microbiome, where it’s needed
  • REBYOTA requires no bowel prep, anesthesia, or colonoscopy
Flowers on a vine

This is Patricia’s Story

For me, it was one dose and one visit, and that was it. I drove myself home and I was fine. Since treatment, I haven’t had any recurrence of C. diff.

Watch Patricia’s Story

Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.

For more information, please talk to your doctor and see full Prescribing Information. Patricia was compensated for her time. Individual results may vary.

Image of Patricia, clinical study patient
Patricia, Clinical Study Patient
Rebyota Patient Brochure

Learn more about C. diff infection and preventing its recurrence with REBYOTA.

Download Brochure

Your REBYOTA Experience

Watch as a nurse shows you what to expect before, during, and after treatment with REBYOTA.

REBYOTA is available by prescription only. Talk to your doctor to find out if REBYOTA is right for you.

Candace, RN, CCRP, was compensated for her time.

Getting ready for treatment with REBYOTA1

Before treatment icon

BEFORE
TREATMENT

No preparation is required

  • You should complete your antibiotic prescription 1 to 3 days before your REBYOTA treatment
  • No bowel prep is required
During treatment icon

DURING
TREATMENT

Administration happens
within minutes

  • Anesthesia or colonoscopy are not necessary
  • The doctor or nurse will place you in the preferred position for the administration
  • You may be asked to remain in place for about 15 minutes to minimize any cramping that may occur
After treatment icon

AFTER
TREATMENT

You can return home

  • Follow your doctor’s instruction

Talk to your doctor…

  • If you have diarrhea 3 or more times a day for 2 days in a row
  • Before taking antibiotics
    for any reason for 8 weeks after treatment with REBYOTA
Flowers on a vine

This is Marty’s Story

After REBYOTA, my symptoms never came back. I’ve had no recurrences.

Watch Marty’s Story

Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.

For more information, please talk to your doctor and see full Prescribing Information. Marty was compensated for his time. Individual results may vary.

Image of Marty, clinical study patient
Marty, Clinical Study Patient

Talking to your doctor about recurrent C. diff and potential treatment options

Create your own customized discussion guide

Answering these questions will help you prepare for a conversation about C. diff with your doctor. This information is completely confidential and will not be saved for other use.

Sign up for more information

Receive additional information and resources to help you through your C. diff infection journey.

What’s your experience with C. diff infection?*(Required)

*Required field.

Consent(Required)

References

  1. REBYOTA. Prescribing Information. Parsippany, NJ: Ferring Pharmaceuticals Inc; 2022.

Please see Important Safety Information and full Prescribing Information

INDICATION

REBYOTA (fecal microbiota, live – jslm) is indicated for the prevention of recurrence of Clostridioides difficile (C. diff) infection in individuals
18 years of age and older, following antibiotic treatment for recurrent C. diff infection.
Limitation of Use
REBYOTA is not indicated for the treatment of C. diff infection.

Important Safety Information

  • You should not receive REBYOTA if you have a history of a severe allergic reaction (e.g., anaphylaxis) to REBYOTA or any of its components.
  • You should report to your doctor any infection you think you may have acquired after administration.
  • REBYOTA may contain food allergens.
  • Most common side effects may include stomach pain (8.9%), diarrhea (7.2%), bloating (3.9%), gas (3.3%), and nausea (3.3%).
  • REBYOTA has not been studied in patients below 18 years of age.
  • Clinical studies did not determine if adults 65 years of age and older responded differently than younger adults.

You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-332-1088.

Please click to see the full Prescribing Information

You are leaving REBYOTA.com

The link you have selected will direct you to a site or resource outside of our website.
Thank you.